Artelo Biosciences Stock Performance
| ARTL Stock | USD 1.20 0.09 6.98% |
The firm shows a Beta (market volatility) of -0.19, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Artelo Biosciences are expected to decrease at a much lower rate. During the bear market, Artelo Biosciences is likely to outperform the market. At this point, Artelo Biosciences has a negative expected return of -0.47%. Please make sure to confirm Artelo Biosciences' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Artelo Biosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in March 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Last Split Factor 1:6 | Dividend Date 2019-06-21 | Last Split Date 2025-06-13 |
1 | Why Artelo Biosciences Inc. stock is favored by top institutions - July 2025 Drop Watch Safe Capital Growth Trade Ideas - B NI V | 11/26/2025 |
2 | Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 Inhibit... | 12/03/2025 |
3 | Artelo Biosciences, Inc. Receives 24.00 Average PT from Brokerages | 12/15/2025 |
4 | Acquisition by Favorito Tamara A of tradable shares of Artelo Biosciences subject to Rule 16b-3 | 12/19/2025 |
5 | Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Cand... | 12/23/2025 |
6 | Artelo Biosciences Adjourns and Reschedules 2025 Annual Meeting - TipRanks | 01/02/2026 |
7 | Artelo Biosciences Inc Stock Analysis and Forecast - Candlestick Trading Patterns Best Stocks For Explosive Growth - earlytimes.in | 01/06/2026 |
8 | Artelo Biosciences, Inc. Sees Significant Decrease in Short Interest | 01/13/2026 |
9 | Stock Analysis Is Artelo Biosciences Inc impacted by rising rates - Weekly Trade Review Accurate Intraday Trading Signals - baoquankhu1.vn | 01/27/2026 |
10 | Acquisition by Gorgas Gregory D. of 154713 shares of Artelo Biosciences at 1.68 subject to Rule 16b-3 | 01/29/2026 |
| Begin Period Cash Flow | 2.8 M | |
| Total Cashflows From Investing Activities | 7.8 M |
Artelo Biosciences Relative Risk vs. Return Landscape
If you would invest 182.00 in Artelo Biosciences on November 17, 2025 and sell it today you would lose (62.00) from holding Artelo Biosciences or give up 34.07% of portfolio value over 90 days. Artelo Biosciences is currently does not generate positive expected returns and assumes 6.4774% risk (volatility on return distribution) over the 90 days horizon. In different words, 58% of stocks are less volatile than Artelo, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Artelo Biosciences Target Price Odds to finish over Current Price
The tendency of Artelo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.20 | 90 days | 1.20 | about 98.0 |
Based on a normal probability distribution, the odds of Artelo Biosciences to move above the current price in 90 days from now is about 98.0 (This Artelo Biosciences probability density function shows the probability of Artelo Stock to fall within a particular range of prices over 90 days) .
Artelo Biosciences Price Density |
| Price |
Predictive Modules for Artelo Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Artelo Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Artelo Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Artelo Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Artelo Biosciences is not an exception. The market had few large corrections towards the Artelo Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Artelo Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Artelo Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.65 | |
β | Beta against Dow Jones | -0.19 | |
σ | Overall volatility | 0.22 | |
Ir | Information ratio | -0.11 |
Artelo Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Artelo Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Artelo Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Artelo Biosciences generated a negative expected return over the last 90 days | |
| Artelo Biosciences has high historical volatility and very poor performance | |
| Artelo Biosciences may become a speculative penny stock | |
| Artelo Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (9.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Artelo Biosciences currently holds about 21.32 M in cash with (8.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Artelo Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Stock Analysis Is Artelo Biosciences Inc impacted by rising rates - Weekly Trade Review Accurate Intraday Trading Signals - baoquankhu1.vn |
Artelo Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Artelo Stock often depends not only on the future outlook of the current and potential Artelo Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Artelo Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.2 M | |
| Cash And Short Term Investments | 2.3 M |
Artelo Biosciences Fundamentals Growth
Artelo Stock prices reflect investors' perceptions of the future prospects and financial health of Artelo Biosciences, and Artelo Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Artelo Stock performance.
| Return On Equity | -4.36 | ||||
| Return On Asset | -1.36 | ||||
| Current Valuation | 2.01 M | ||||
| Shares Outstanding | 2.02 M | ||||
| Price To Earning | 16.31 X | ||||
| Price To Book | 0.50 X | ||||
| EBITDA | (10.11 M) | ||||
| Net Income | (9.83 M) | ||||
| Cash And Equivalents | 21.32 M | ||||
| Cash Per Share | 7.51 X | ||||
| Total Debt | 104 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 42.28 X | ||||
| Book Value Per Share | (0.41) X | ||||
| Cash Flow From Operations | (8.35 M) | ||||
| Earnings Per Share | (19.50) X | ||||
| Market Capitalization | 3.51 M | ||||
| Total Asset | 4.7 M | ||||
| Retained Earnings | (50.14 M) | ||||
| Working Capital | 785 K | ||||
| Current Asset | 99.89 M | ||||
| Current Liabilities | 23.67 M | ||||
About Artelo Biosciences Performance
By examining Artelo Biosciences' fundamental ratios, stakeholders can obtain critical insights into Artelo Biosciences' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Artelo Biosciences is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (3.33) | (3.49) | |
| Return On Capital Employed | (3.97) | (3.77) | |
| Return On Assets | (1.88) | (1.98) | |
| Return On Equity | (3.96) | (3.76) |
Things to note about Artelo Biosciences performance evaluation
Checking the ongoing alerts about Artelo Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Artelo Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Artelo Biosciences generated a negative expected return over the last 90 days | |
| Artelo Biosciences has high historical volatility and very poor performance | |
| Artelo Biosciences may become a speculative penny stock | |
| Artelo Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (9.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Artelo Biosciences currently holds about 21.32 M in cash with (8.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Artelo Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Stock Analysis Is Artelo Biosciences Inc impacted by rising rates - Weekly Trade Review Accurate Intraday Trading Signals - baoquankhu1.vn |
- Analyzing Artelo Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Artelo Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Artelo Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Artelo Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Artelo Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Artelo Biosciences' stock. These opinions can provide insight into Artelo Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Artelo Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Artelo Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Artelo Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Artelo Biosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.